Christian Riedel
Hello, all people. Welcome to this PTX Investor Briefing. Whereas individuals settle in, I will simply present the disclaimer for the session shortly.
The displays that we host are appropriate for self-directed traders who’ve the expertise and capabilities to make their very own knowledgeable choices. Any data contained in right now’s presentation is normal nature doesn’t contemplate your private circumstances to think about for your self and is acceptable for you. The data we’re providing you with is for academic functions solely. Previous efficiency not a dependable indicator of future efficiency.
Nice. With that, let’s kick off the session. I am Christian Riedel, Govt Director at Attain. I will be internet hosting the session right now. Many may know me from the latest capital increase the place James and I did simply fairly just a few of those webcasts to each shareholders and potential new traders. James is right here with me, James McDonnell, CEO of Prescient. And right now’s replace is off the again of their latest 4C announcement, which included an replace on the Section IIa research for most cancers therapy of PTX-100 with 7 medical websites now open in Australia and the U.S.
How we will run the session is I will first ask James just a few questions concerning the latest information, latest releases, after which I will let him run by the deck. Will probably be, I believe, a mix of, the traditional deck and likewise the AGM presentation and reflecting a few of these new releases. After which we will comply with up with some Q&A to catch something we’ve not lined and likewise open the ground to the viewers right here to get an replace. We count on the session to
Keep forward of the curve with NextBusiness 24. Discover extra tales, subscribe to our e-newsletter, and be part of our rising group at nextbusiness24.com